You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MVA85A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety, Immunogenicity Trial in Entebbe, Oxford (ChAdOx185A, MVA85A, BCG)

Active, not recruiting
  • Safety
  • Immunogenicity
  • ChAdOx185A
  • +2 more
  • Entebbe, Uganda
  • +1 more
May 13, 2021

Tuberculosis Trial in Oxford, Birmingham, London (Aerosol inhaled MVA85A, Intramuscular MVA85A, Intramuscular Saline )

Terminated
Has Results
  • Tuberculosis
  • Aerosol inhaled MVA85A
  • +3 more
  • Oxford, Oxfordshire, United Kingdom
  • +4 more
Aug 14, 2020

Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)

Terminated
Has Results
  • Microvascular Coronary Artery Disease
  • Los Angeles, California
  • +9 more
Mar 15, 2022

Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)

Active, not recruiting
  • Healthy
  • Ad26.ZEBOV
  • MVA-BN-Filo
  • Cuangugu, Rwanda
  • +2 more
Jan 17, 2023

Covid19 Trial (MVA-SARS-2-S, Placebo)

Withdrawn
  • Covid19
  • MVA-SARS-2-S
  • Placebo
  • (no location specified)
Jul 17, 2023

Ebola Virus Disease Trial in Freetown (Ad26.ZEBOV, MVA-BN-Filo, MenACWY)

Completed
Has Results
  • Ebola Virus Disease
  • Ad26.ZEBOV
  • +3 more
  • Freetown, Sierra Leone
    (unnamed)
Jun 22, 2022

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)

Recruiting
  • COVID-19 Vaccines
  • MVA-SARS-2-ST
  • Hannover, Germany
    Hannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022

Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

Not yet recruiting
  • Chronic Hepatitis B
  • HEPLISAV B; TherVacB
  • TherVacB
  • Hamburg, Germany
    CTC North
Feb 3, 2023

HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))

Completed
  • HIV
  • ChAdOx1.tHIVconsv1 (C1)
  • +2 more
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022

First Trimester Abortion, Surgical Abortion, Miscarriage With Afibrinogenemia Trial (MateRegen® gel (BioRegen))

Recruiting
  • First Trimester Abortion
  • +2 more
  • MateRegen® gel (BioRegen)
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Oct 30, 2022

Hemorrhagic Fever, Ebola Trial in Worldwide (Ad26.ZEBOV, MVA-BN-Filo, Placebo)

Completed
Has Results
  • Hemorrhagic Fever, Ebola
  • Ad26.ZEBOV
  • +2 more
  • BoboDioulasso, Burkina Faso
  • +6 more
Feb 9, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Healthy Trial in Oxford (ChAdOx1.HTI and MVA.HTI)

Completed
  • Healthy
  • ChAdOx1.HTI and MVA.HTI
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 31, 2022

Virus Diseases, Hemorrhagic Fever, Ebola, Infections Trial in Kambia (Ad26.ZEBOV, MVA-BN-Filo)

Recruiting
  • Virus Diseases
  • +10 more
  • Ad26.ZEBOV, MVA-BN-Filo
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Oct 11, 2022

Covid19 Trial in Cologne, Hamburg (MVA-SARS-2-ST)

Active, not recruiting
  • Covid19
  • MVA-SARS-2-ST
  • Cologne, NRW, Germany
  • +1 more
Jun 21, 2022

Antibiotic Side Effect, Probiotics, Diarrhea Trial in Barcelona (Probiotic Lactobacillus acidophilus LA85)

Completed
  • Antibiotic Side Effect
  • +2 more
  • Probiotic Lactobacillus acidophilus LA85
  • Barcelona, Castelldefels, Spain
    Ciurana Clinic
Jul 25, 2023

RSV Infection Trial in London (MVA-mBN294B, Placebo)

Completed
  • RSV Infection
  • MVA-mBN294B
  • Placebo
  • London, United Kingdom
    hVIVO Services Limited
Mar 31, 2022

Myopia, Progressive Trial (IVMED 85, Placebo)

Not yet recruiting
  • Myopia, Progressive
  • IVMED 85
  • Placebo
  • (no location specified)
Mar 7, 2023

Recurrent Wheezing, Wheezing Lower Respiratory Illness Trial (OM-85, Placebo)

Not yet recruiting
  • Recurrent Wheezing
  • Wheezing Lower Respiratory Illness
  • (no location specified)
May 15, 2023

Malaria,Falciparum Trial in Kilifi (R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection

Recruiting
  • Malaria,Falciparum
  • R21/Matrix-M
  • +2 more
  • Kilifi, Kenya
    KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
Sep 14, 2022

Infertility, Female, IVF, Reproductive Disorder Trial in Nanjing (Mevalproic acid)

Recruiting
  • Infertility, Female
  • +3 more
  • Mevalproic acid
  • Nanjing, Jiangsu, China
    Reproductive Medicine Center, The affiliated Drum Towel Hospital
Mar 28, 2023

HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,

Recruiting
  • HIV Infection
  • ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
  • Normal saline solution
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Jul 11, 2022

Solid Tumor, Adult Trial in United States (GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose)

Recruiting
  • Solid Tumor, Adult
  • GAd-209-FSP low dose
  • +5 more
  • Duarte, California
  • +12 more
Oct 2, 2022

Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide

Recruiting
  • Cytomegaloviral Infection
  • Hematopoietic Cell Transplant Recipient
  • Laboratory Biomarker Analysis
  • Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
  • Duarte, California
    City of Hope Medical Center
Jun 14, 2022